Medication guide
Apomorphine for ED: Evidence, Risks and Questions
Apomorphine has been studied for erectile dysfunction, but evidence for older sublingual tablets does not establish that a compounded combination gummy works the same way. Understanding the formulation, evidence and interactions matters more than the number of ingredients.
Published by StiffiesRx. Prepared with AI assistance using the sources below. StiffiesRx sells prescription compounded ED products and has a commercial interest in this topic.
What is apomorphine, and why is it in some ED products?
Apomorphine acts on dopamine receptors, a different mechanism from the blood-flow pathway targeted by sildenafil and tadalafil. That distinction explains interest in it for erectile dysfunction. It does not establish that adding it improves every patient’s results, increases attraction or treats performance anxiety.
The name can also cause confusion. Apomorphine is a different drug from morphine. Do not use its name, an ingredient count or a phrase such as “brain and body” as a substitute for understanding the prescription.
What does the ED research actually show?
A 2020 systematic review included nine randomized trials of sublingual apomorphine. The trials were short, generally four to eight weeks. Results favored apomorphine over placebo on several measures, but benefits were not consistent across all populations, and adverse effects caused more discontinuations at higher doses. These were studies of particular sublingual formulations, not StiffiesRx gummies. [1]
Apomorphine is also not proven superior to sildenafil. In a small randomized crossover comparison, sildenafil performed better; only 34 participants were evaluable, which limits how broadly the findings can be applied. [2]
Ask whether the supporting study tested the same ingredients, amounts, dosage form and patient group. A study of one ingredient taken under the tongue cannot answer every question about a multi-ingredient chewable.
FDA approval and compounded products are different questions
The U.S. APOKYN label covers an injectable apomorphine treatment for Parkinson’s disease. That approval does not establish approval of an ED gummy. [3] Compounded drugs are not FDA-approved, and FDA does not evaluate them for safety, effectiveness or quality before marketing. [4]
When comparing a tablet, a sublingual product and a gummy, keep their evidence separate. Ask the clinician why the proposed formulation fits your needs and whether an approved single-ingredient treatment would be appropriate. A transparent answer should identify the reason for the prescription without implying that more ingredients automatically mean better care.
Side effects and interactions to discuss
The apomorphine label includes risks such as nausea, dizziness, low blood pressure, fainting and sleepiness. It contraindicates use with 5-HT3 antagonists such as ondansetron because severe low blood pressure and loss of consciousness have been reported. The injection label identifies hazards; it does not provide a dosing guide for an ED gummy. [3]
Share the exact names of all medicines you use, including anti-nausea medication. If a compounded product also contains sildenafil or tadalafil, it also carries the interaction concerns of those ingredients. In particular, do not combine a PDE5 inhibitor with nitrates or poppers. See our poppers safety guide.
Five questions for your prescribing appointment
- What problem are we trying to solve? Describe whether the issue is erection firmness, maintaining an erection, desire, anxiety or orgasm.
- Why this formulation? Ask what makes it appropriate for your health and treatment history.
- What evidence applies to this exact product? Separate direct research from an inference about ingredients.
- What should I do if I feel unwell? Get a plan for side effects and urgent symptoms before using it.
- How will we judge whether it helps? Agree on a follow-up plan rather than changing the dose yourself.
You do not need to select an ingredient before starting a care conversation. A useful evaluation begins with your symptoms, medications and goals.
Where StiffiesRx fits
StiffiesRx offers prescription compounded ED gummies; some tiers include apomorphine. Check the current product formulas and your own prescription for the exact ingredients. A licensed provider determines whether treatment is appropriate. StiffiesRx has a commercial interest in the products discussed here.
For a comparison of the better-established tablet options, read sildenafil versus tadalafil. If a previous treatment has not helped, bring that history to the clinician rather than adding another medicine on your own.
Sources
Keep reading
Care starts with your circumstances
A licensed provider can review your symptoms, health and treatment history. A prescription is issued only when clinically appropriate.
Explore a care evaluation →Educational information, not an individual diagnosis or treatment plan. Follow your prescription and ask your clinician about changes. Compounded drugs are not FDA-approved; FDA does not evaluate their safety, effectiveness or quality before marketing. Seek urgent care for emergency symptoms.
StiffiesRx offers safe, effective ED treatments with the convenience you need—HIPAA-compliant, discreetly shipped, and backed by US-based doctors.
© 2025 StiffiesRx. All rights Reserved.
